Overcoming Preclinical Hurdles in Neuro-Drug Discovery

أضاف وظيفة جديدة Health

2026-07-24 05:43:59 -

The development of therapeutics for central nervous system (CNS) disorders, particularly neurodegenerative conditions like Alzheimer's disease, presents some of the highest attrition rates in the pharmaceutical sector. For decades, drug developers have hit a major industry pain point: the translational gap. Traditional preclinical pipelines rely heavily on two-dimensional (2D) cell cultures and...

0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة